Stent Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Drug-Eluting Stent, Bare Metal Coronary Stent, and Bioabsorbable Stent), By Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, and Natural Biomaterial), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition

Industry : Healthcare
Pages : NA
Published Date : NA

Customization Enquiry

Buy Now

Single User Licence

$4500

Multi-User Licence

$5500

Custom Research Licence

$8000

Summary

Request Sample

Report Description

Forecast Period	2024-2028
Market Size (2022)	USD 10.06 Billion
CAGR (2023-2028)	6.46%
Fastest Growing Segment	Hospitals & Clinics
Largest Market	North America

Market Overview

Global Stent Market has valued at USD 10.06 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.46% through 2028. A stent is a small, mesh tube used to maintain patency in narrowed or weakened passages within the body, such as arteries. It is commonly employed in the treatment of stenosed coronary arteries responsible for supplying oxygen-rich blood to the heart. The procedure of placing a stent in the body is known as stenting. One of the primary applications of stents is to restore blood flow in vessels obstructed by plaque. Plaque typically consists of fat, cholesterol, and other substances present in the bloodstream. Over time, this plaque adheres to the arterial walls, progressively reducing the amount of oxygenated blood reaching the body. The accumulation of plaque can lead to the development of coronary heart disease.

Individuals with plaque build-up may experience warning signs, such as chest pain. Without timely intervention, they face an elevated risk of complications, including stroke or heart attack. To prevent arterial blockage or excessive narrowing, healthcare providers employ stents, which facilitate uninterrupted blood flow. Stents are available in various types, most commonly crafted from a plastic or metal mesh-like material. However, stent grafts, composed of fabric, are used in larger arteries. Furthermore, stents can be coated with medications to inhibit closure of the obstructed artery, promoting long-term patency.

Key Market Drivers

Increasing Prevalence of Chronic Diseases

The escalating prevalence of chronic diseases worldwide is significantly driving the demand for stents, a vital component of modern clinical therapeutics. Chronic conditions such as coronary artery disease, peripheral artery disease, and kidney diseases often result in the narrowing of blood vessels, obstructing the smooth flow of blood. Stents, small mesh tubes that are used to treat narrowed or weakened arteries in the body, present an effective solution to this problem.

The surge in cases of diabetes and obesity, primarily due to sedentary lifestyles and unhealthy eating habits, is contributing to an upswing in vascular diseases. This, in turn, is propelling the need for stenting procedures. Moreover, the aging population is increasingly susceptible to chronic diseases, adding to the impetus for stent demand.

In a bid to meet this burgeoning demand, medical device manufacturers are focusing on the development of advanced stents, characterized by improved designs, biocompatibility, and drug-eluting properties. The advancements in minimally invasive surgical procedures are also boosting the adoption of these devices. In light of these integral roles that stents play in responding to chronic diseases, it is anticipated that the demand of stents to continue on an upward trajectory. This makes stents a focal point in healthcare strategies globally, with a particular emphasis on enhancing their effectiveness, accessibility, and affordability.

Increasing Geriatric Population

As individuals age, their risk of developing cardiovascular diseases such as coronary artery disease (CAD) and peripheral arterial disease (PAD) significantly increases. Stents are a crucial medical device used to treat these conditions by reopening blocked or narrowed arteries, improving blood flow, and preventing serious complications like heart attacks and strokes. The elderly often contends with multiple chronic health conditions, including diabetes and hypertension, which can accelerate the development and progression of atherosclerosis. Stents are frequently employed to address the consequences of these conditions by maintaining the patency of blood vessels. Ongoing research and development in stent technology have led to the creation of more advanced and innovative devices. Drug-eluting stents, for instance, release medication to reduce the risk of restenosis or re-narrowing of the treated artery. These technological advancements have improved the efficacy and safety of stent procedures, making them more suitable for older patients.

Stent placement is typically performed through minimally invasive procedures, which are often preferred for older patients who may have additional health concerns. These procedures offer quicker recovery times and reduce post-operative complications compared to traditional open surgeries. The increasing geriatric population is a significant driver behind the rising demand for stents. As older individuals become more susceptible to cardiovascular diseases and other chronic health conditions, the need for interventional procedures like stent implantation is expected to grow. The development of innovative stent technologies and minimally invasive techniques further supports the utilization of stents in addressing the healthcare needs of the elderly, ultimately improving their overall quality of life and longevity.

Technological Advancements in Stent Development

The growing demand for advanced technology in the field of medical science and healthcare has led to a significant boost in the demand for stents in the market. With an increasing number of individuals from the geriatric age group requiring medical intervention, stents have become a crucial component in addressing their healthcare needs. Moreover, the availability of higher disposable income has empowered individuals to opt for cutting-edge technologies and equipment that provide superior outcomes following surgical procedures.

The utilization of these state-of-the-art technologies has instilled confidence in potential consumers, assuring them of the effectiveness and reliability of surgical procedures and techniques. This not only enhances patient satisfaction but also contributes to the overall growth of the stent market. Furthermore, the recent advancements witnessed in the wake of the pandemic outbreak, such as the development of innovative stent designs and materials, have further contributed to the expansion of the stent market.

These developments have created new opportunities for growth and innovation in this crucial medical field, paving the way for advancements in stent technology to meet the evolving needs of patients and healthcare providers alike. As the demand for advanced medical solutions continues to rise, the stent market is poised for further expansion and progress, playing a vital role in improving patient outcomes and enhancing the quality of healthcare.

Increasing Demand for Surgical Procedures

In recent years, there has been a noticeable and gradual increase in the demand for advanced surgical procedures that utilize minimally invasive techniques. These cutting-edge methods have revolutionized the field of surgery, providing patients with less invasive options and faster recovery times. One area that has particularly benefited from these advancements is cardiovascular surgery. The introduction of modern equipment and devices has greatly improved the success rates and outcomes of surgical procedures related to the cardiovascular system. In particular, the use of stents has become increasingly common, offering effective solutions for patients suffering from severe blockages caused by high cholesterol levels.

The demand for surgical interventions is further fueled by the preferences of the geriatric population. With limited time to wait for the effects of medications, many older patients opt for surgical procedures as a more immediate solution to their cardiovascular conditions. This growing demand for surgical interventions presents a significant opportunity for market growth in the forecast period. As the number of people worldwide suffering from severe cardiovascular diseases continues to rise, the market for advanced surgical procedures and related products is poised for long-term expansion. Overall, these trends highlight the need for continuous innovation in the field of minimally invasive surgery and the potential for significant advancements in patient care and outcomes.

Download Free Sample Report

Key Market Challenges

Unfavorable Government Regulations

The growth of the stent market has been significantly hindered by numerous rules and regulations that are directly associated with the development of modern technologies. These regulations, imposed by the government, have posed major challenges and obstacles to the market's expansion. The unfavorable government regulations and guidelines have not only affected the market in the short term but also have the potential to impede its growth in the long run.

One of the key areas where these obstacles have been experienced is in terms of insurance coverage. The regulations surrounding insurance coverage for stent procedures have made it difficult for common people to access and afford these modern technologies. Additionally, the burden of taxes further adds to the financial challenges faced by individuals seeking stent treatment. The stent market faces significant hurdles due to the complex web of regulations and guidelines imposed by the government. These barriers not only limit the growth potential of the market but also restrict the accessibility of modern technologies for those who could benefit from them.

High Product Recalls

Recalls of stents due to safety issues erode patient confidence in the effectiveness and safety of these devices. When patients and healthcare providers perceive a higher risk associated with stents, they may opt for alternative treatments or approaches, leading to reduced demand. Repeated recalls often attract the attention of regulatory authorities, prompting more rigorous oversight of stent manufacturing and quality control processes. While this is essential for patient safety, it can lead to delays in product approvals and market launches, limiting the availability of stents and reducing demand. High-profile recalls can generate negative publicity, which can further erode public trust in stent products. This perception can influence patients' decisions and reduce their willingness to undergo stent procedures, even when medically indicated.

High product recalls in the stent industry have created a challenging environment, characterized by decreased patient trust, regulatory scrutiny, and increased competition. These factors collectively contribute to the diminishing demand for stent procedures and products, underscoring the importance of rigorous quality control and safety measures to maintain the credibility and viability of stent manufacturers in the healthcare market.

Key Market Trends

Non-Invasive Procedures Options

The increasing demand for minimally invasive surgical procedures and management has significantly boosted the demand for advanced stents, which are crucial in supporting and enhancing patient outcomes. These innovative medical devices play a vital role in providing effective treatment options with minimal disruption to the body.

Minimally invasive surgical procedures have proven to be highly beneficial for the healing process, allowing patients to recover faster and experience reduced post-operative complications. However, it is worth noting that these procedures often require a longer duration to ensure optimal results and promote complete recovery. In contrast, non-invasive surgical procedures have emerged as a promising alternative for patients, particularly those with diabetes. These procedures offer faster healing and recovery times, empowering patients to regain their health and well-being more rapidly.

The increasing demand for modern technologies in the healthcare sector has created a remarkable opportunity for the growth of the stents market. With healthcare providers and patients alike seeking advanced solutions and improved outcomes, the demand for cutting-edge stents continues to rise globally. This growing market presents immense potential for innovation and development, driving the healthcare industry towards enhanced patient care and improved quality of life.

Unhealthy Lifestyle and Sedentary Habits

As a result of modern lifestyle practices and sedentary habits, the overall health of people has severely deteriorated. The rise in cardiovascular disorders among patients has been alarming, with a rapid increase over time. In order to address this critical issue, patients with major blockages require the utilization of advanced stents, which not only provide effective treatment but also contribute significantly to the growth of the market.

Furthermore, the prevalence of a stressful work schedule and busy lifestyle has had a profound impact on the cardiac health of individuals. This emerging trend presents a significant opportunity for the stent market to expand and cater to the increasing demand for innovative solutions. By addressing the specific needs of patients and offering advanced stent technologies, the market can play a vital role in improving overall cardiac health and enhancing the quality of life for many individuals.

Segmental Insights

Biomaterial Insights

Based on the biomaterial, the market is segmented into metallic biomaterial, polymeric biomaterial, and natural biomaterial. In 2022, the Metallic Biomaterial segment has emerged as the dominant force in the market. With a sharp focus on the production of stents for cardiovascular diseases, manufacturers in this industry are proactively increasing their efforts. The utilization of these metallic stents is projected to witness a notable surge alongside the rise in endoscopy and fluoroscopy cases.

Furthermore, the growth trajectory of the polymeric bio-materials segment is also anticipated to gain momentum in the upcoming years. The demand for polymeric stents has witnessed a significant upswing, largely driven by the escalating cases of cardiovascular diseases. Moreover, the government's increasing approval of this type of stent further bolsters market prospects, indicating a promising future for this segment.

End User Insights

Based on the end user, the segment of the hospital has emerged as the largest segment as most of the procedures are carried out within a hospital setup. A hospital setup provides a wide range of facilities to both patients and medical staff, creating a conducive environment for carrying out surgical procedures. With state-of-the-art equipment and a dedicated team of healthcare professionals, hospitals ensure the highest level of care and safety during these procedures.

Furthermore, it is extremely essential to closely monitor the other vital parameters of the patient throughout the procedure, which can be efficiently done within a well-equipped hospital setup. This constant monitoring helps in detecting any potential complications or deviations, allowing for timely intervention and ensuring the best possible outcomes for the patients. In addition to hospitals, the ambulatory surgical center segment is also expected to witness significant growth. These centers offer specialized surgical services on an outpatient basis, providing convenience and cost-effectiveness to patients. With advancements in medical technology and increasing demand for minimally invasive procedures, ambulatory surgical centers are becoming an integral part of the healthcare landscape.

Overall, the availability of multiple facilities within hospitals and the rise of ambulatory surgical centers contribute to the growth and expansion of surgical treatments, ensuring that patients receive the highest quality care in a suitable healthcare setting.

Download Free Sample Report

Regional Insights

Based on geographical analysis, the North America region has emerged as the largest market for stents, attributable to the substantial patient population residing in this area. A significant portion of the North American population falls within the geriatric age group, leading to sedentary lifestyles and an increased incidence of cardiovascular diseases. The growing demand for minimally invasive surgical procedures, fueled by the weak healing capacity of the geriatric population, has contributed to the rapid expansion of the stents market. Furthermore, the rising cholesterol levels resulting from modern lifestyle practices and sedentary habits have led to the occurrence of severe blockages in the heart's lumen, necessitating surgical management. The availability of state-of-the-art healthcare facilities in hospitals has further augmented the market in this region.

Similarly, the European region has witnessed a growing market for stents due to the advanced healthcare services provided by the government. The European population's utilization of modern healthcare services has led to a demand for advanced surgical options and the utilization of cutting-edge equipment.

Recent Developments

May 2022: Medtronic obtained US FDA approval for the Onyx Frontier drug-eluting stent (DES).
April 2022: Translumina, a producer and manufacturer of cardiovascular medical devices used in interventional cardiology, launched VIVO ISAR, its dual drug polymer-free coated stent (DDCS), in various international markets, including Europe.
December 2020: Microport Scientific received a registration certificate from the National Medical Products Administration of China for the Bridge vertebral drug-eluting stent. The certificate featured a unique drug delivery design that enables faster endothelialization.

Key Market Players

Medtronic plc
B. Braun Melsungen AG
Terumo Corporation
STENTYS SA
MicroPort Scientific Corporation
Meril Life Sciences Pvt. Ltd
Translumina GmbH
Biosensors International Group Limited
Boston Scientific Corporation
BIOTRONIK SE & Co. KG

By Product Type		By Biomaterial	By End User	By Region
	Drug-Eluting Stent Bare Metal Coronary Stent Bioabsorbable Stent	Metallic Biomaterial Polymeric Biomaterial Natural Biomaterial	Hospitals & Clinics Ambulatory Surgical Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Stent Market, By Product Type:

o Drug-Eluting Stent

o Bare Metal Coronary Stent

o Bioabsorbable Stent

Stent Market, By Biomaterial:

o Metallic Biomaterial

o Polymeric Biomaterial

o Natural Biomaterial

Stent Market, By End User:

o Hospitals & Clinics

o Ambulatory Surgical Centres

o Others

Stent Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ United Kingdom

§ Italy

§ Germany

§ Spain

o Asia-Pacific

§ China

§ India

§ Japan

§ Australia

§ South Korea

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

§ Kuwait

§ Turkey

§ Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Stent Market.

Available Customizations:

Global Stent market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Stent Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validations

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Stent Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product Type (Drug-Eluting Stent, Bare Metal Coronary Stent, and Bioabsorbable Stent)

5.2.2. By Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, and Natural Biomaterial)

5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Others)

5.2.4. By Region

5.2.5. By Company (2022)

5.3. Market Map

6. North America Stent Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product Type

6.2.2. By Biomaterial

6.2.3. By End User

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Stent Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product Type

6.3.1.2.2. By Biomaterial

6.3.1.2.3. By End User

6.3.2. Canada Stent Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product Type

6.3.2.2.2. By Biomaterial

6.3.2.2.3. By End User

6.3.3. Mexico Stent Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product Type

6.3.3.2.2. By Biomaterial

6.3.3.2.3. By End User

7. Europe Stent Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product Type

7.2.2. By Biomaterial

7.2.3. By End User

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Stent Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product Type

7.3.1.2.2. By Biomaterial

7.3.1.2.3. By End User

7.3.2. United Kingdom Stent Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product Type

7.3.2.2.2. By Biomaterial

7.3.2.2.3. By End User

7.3.3. Italy Stent Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecasty

7.3.3.2.1. By Product Type

7.3.3.2.2. By Biomaterial

7.3.3.2.3. By End User

7.3.4. France Stent Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product Type

7.3.4.2.2. By Biomaterial

7.3.4.2.3. By End User

7.3.5. Spain Stent Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product Type

7.3.5.2.2. By Biomaterial

7.3.5.2.3. By End User

8. Asia-Pacific Stent Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product Type

8.2.2. By Biomaterial

8.2.3. By End User

8.2.4. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Stent Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product Type

8.3.1.2.2. By Biomaterial

8.3.1.2.3. By End User

8.3.2. India Stent Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product Type

8.3.2.2.2. By Biomaterial

8.3.2.2.3. By End User

8.3.3. Japan Stent Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product Type

8.3.3.2.2. By Biomaterial

8.3.3.2.3. By End User

8.3.4. South Korea Stent Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product Type

8.3.4.2.2. By Biomaterial

8.3.4.2.3. By End User

8.3.5. Australia Stent Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product Type

8.3.5.2.2. By Biomaterial

8.3.5.2.3. By End User

9. South America Stent Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product Type

9.2.2. By Biomaterial

9.2.3. By End User

9.2.4. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Stent Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product Type

9.3.1.2.2. By Biomaterial

9.3.1.2.3. By End User

9.3.2. Argentina Stent Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product Type

9.3.2.2.2. By Biomaterial

9.3.2.2.3. By End User

9.3.3. Colombia Stent Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product Type

9.3.3.2.2. By Biomaterial

9.3.3.2.3. By End User

10. Middle East and Africa Stent Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product Type

10.2.2. By Biomaterial

10.2.3. By End User

10.2.4. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Stent Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product Type

10.3.1.2.2. By Biomaterial

10.3.1.2.3. By End User

10.3.2. Saudi Arabia Stent Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product Type

10.3.2.2.2. By Biomaterial

10.3.2.2.3. By End User

10.3.3. UAE Stent Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product Type

10.3.3.2.2. By Biomaterial

10.3.3.2.3. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Global Stent Market: SWOT Analysis

14. Porter’s Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview

15.2. Service Offerings

15.3. Recent Developments

15.4. Key Personnel

15.5. SWOT Analysis

15.5.1. Medtronic plc

15.5.2. B. Braun Melsungen AG

15.5.3. Terumo Corporation

15.5.4. STENTYS SA

15.5.5. MicroPort Scientific Corporation

15.5.6. Meril Life Sciences Pvt. Ltd

15.5.7. Translumina GmbH

15.5.8. Biosensors International Group Limited

15.5.9. Boston Scientific Corporation

15.5.10. BIOTRONIK SE & Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer

Figures and Tables

Frequently asked questions

What was the market size of the Global Stent Market in 2022?

The market size of the Global Stent Market was estimated to be USD 10.06 Billion in 2022.

Which was the dominant segment by product type in the Global Stent Market in 2022?

Within the product category, the drug-eluting stent is expected to significantly contribute to the market. This is attributed to its favorable treatment outcomes and lower re-obstruction rate. The stent is coated with a time-release medication, gradually releasing it into the blood vessel to prevent blockages. By preventing plaque buildup, drug-eluting stents alleviate chest pain and improve blood flow to the heart, thereby reducing the risk of heart attacks. Typically, these stents are constructed with a metallic polymer coating combined with an antirestenotic drug.

Which is the dominant region in the Global Stent Market?

North America is expected to have a significant market share due to the increasing patient population with coronary heart diseases and investment in healthcare facilities. The presence of numerous coronary stents manufacturers in the US has raised awareness about the risk factors associated with coronary heart diseases, contributing to the market growth in the region. The Asia-Pacific region is projected to experience lucrative growth in the future. Economic developments, government reforms, especially in China and India, support the regional market growth. Additionally, a large aging population with cardiovascular disease, rising PCI procedures, improved reimbursement, and low manufacturing costs of coronary stents in the region drive the market growth. Factors like increased smoking addiction and western culture influence among adults also contribute to market growth.

What are the major drivers for the Global Stent Market?

Global health care expenditure and growing diabetic population are the major drivers for the Global Stent Market.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

Stent Market to Grow with a CAGR of 6.46% through 2028

Sep, 2023

Surge in prevalence of heart diseases and increase in demand for angioplasty is expected to drive the Global Stent Market growth in the forecast period, 2024-2028.